Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Skin Ulcer

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    126 result(s) found for: Skin Ulcer. Displaying page 1 of 7.
    1  2  3  4  5  6  7  Next»
    EudraCT Number: 2021-002212-31 Sponsor Protocol Number: NEMUS Start Date*: 2021-09-27
    Sponsor Name:MIMETECH SRL
    Full Title: NEurotrophins Mimetic compound for the treatment of diabetic foot UlcerS
    Medical condition: Diabetic Foot Ulcer
    Disease: Version SOC Term Classification Code Term Level
    24.0 100000004858 10012664 Diabetic foot ulcer LLT
    24.0 100000004858 10012664 Diabetic foot ulcer LLT
    24.0 100000004858 10012664 Diabetic foot ulcer LLT
    24.0 100000004858 10012664 Diabetic foot ulcer LLT
    24.0 100000004858 10012664 Diabetic foot ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2022-002321-10 Sponsor Protocol Number: PR11/2022 Start Date*: 2023-01-16
    Sponsor Name:Hospital Universitari d'Igualada
    Full Title: Effectiveness and safety of topical sevoflurane for the treatment of painful skin ulcers; randomized, double-blind, placebo-controlled clinical trial
    Medical condition: Cutaneous complex ulcers (grade II, III and IV) which are painful and require hospital care
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10065043 CMV mucocutaneous ulcer LLT
    21.0 100000004858 10045334 Ulcer skin LLT
    20.0 100000004858 10016980 Foot ulcer LLT
    20.0 100000004858 10077779 Pressure ulcer LLT
    21.0 100000004858 10077409 Ischemic skin ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-000202-20 Sponsor Protocol Number: RC-P0041 Start Date*: 2015-06-22
    Sponsor Name:Groupement des Hôpitaux de l’Institut Catholique de Lille (GHICL)
    Full Title: Effect and tolerance of ketamine's subcutaneous bolus during painful care, refractory of bedsore, ulcer, vascular wound care in palliative care units.
    Medical condition: Patients’ palliative care for bedsores, ulcers or vascular wounds, which are general characteristics of the patient population that will be included: usually elderly, undernourished and of multiple...
    Disease: Version SOC Term Classification Code Term Level
    18.0 10047065 - Vascular disorders 10047079 Vascular injuries HLGT
    18.0 10018065 - General disorders and administration site conditions 10045285 Ulcer PT
    18.0 10040785 - Skin and subcutaneous tissue disorders 10036651 Pressure sore LLT
    18.0 10042613 - Surgical and medical procedures 10059513 Palliative care PT
    18.0 10040785 - Skin and subcutaneous tissue disorders 10040943 Skin ulcer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-019887-35 Sponsor Protocol Number: ABH-DERMAGRAFT-001-09 Start Date*: 2010-09-06
    Sponsor Name:Advanced BioHealing Inc
    Full Title: A Prospective, Multi-center, Longitudinal Cohort Study of Dermagraft® in Subjects with Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
    Medical condition: Venous leg ulcers
    Disease: Version SOC Term Classification Code Term Level
    9.1 10024134 Leg ulcer (exc varicose) LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) EE (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-001551-38 Sponsor Protocol Number: ghnhsft Start Date*: 2005-09-29
    Sponsor Name:Gloucestershire Hospitals NHS Foundation Trust
    Full Title: A study to research if foam sclerotherapy of saphenous trunks can speed up the healing of chronic venous leg ulcers
    Medical condition: We will include patients with insufficiency of the long and/or short saphenous vein as underlying cause of their venous leg ulcer. These patients may or may not have visible varicose veins of the l...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-002695-34 Sponsor Protocol Number: CS-201 Start Date*: 2009-01-23
    Sponsor Name:Kringle Pharma Europe AB
    Full Title: A Phase I/II Double-Blind, Dose Ranging, Vehicle Controlled, Randomized, Parallel Groups, Safety, Tolerability and Efficacy Study of ChronSeal® (5-amino-acid deleted recombinant human Hepatocyte Gr...
    Medical condition: Non-malignant full skin chronic venous leg ulcers of an area 3 - 20 cm2.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047260 Venous ulceration LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2019-001483-30 Sponsor Protocol Number: BBH-GMCSF-01 Start Date*: 2020-06-18
    Sponsor Name:Reponex Pharmaceuticals A/S
    Full Title: Effect of topical rhGM-CSF on the healing of venous leg ulcers: a randomized, placebo-controlled, double-blind, clinical phase II study
    Medical condition: Venous leg ulcers
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004858 10047260 Venous ulceration LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-015749-22 Sponsor Protocol Number: ADATOP Start Date*: 2010-12-22
    Sponsor Name:University of Leipzig
    Full Title: A prospective, monocentric clinical trial with adalimumab for topical treatment in chronic wounds
    Medical condition: Chronic stasis ulcer
    Disease: Version SOC Term Classification Code Term Level
    13.1 10040785 - Skin and subcutaneous tissue disorders 10047246 Venous stasis ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-004782-11 Sponsor Protocol Number: 2002C014G Start Date*: 2017-12-05
    Sponsor Name:Prometic Biotherapeutics Ltd
    Full Title: A Phase 1/2A Prospective, Dose-Escalation, Open-Label Study of the Safety, Feasibility, and Initial Efficacy of Subcutaneous Plasminogen (Human) 10 for the Treatment of Diabetic Foot Ulcer
    Medical condition: Diabetic foot ulcer (DFU)
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000014568 10012664 Diabetic foot ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2015-002180-41 Sponsor Protocol Number: DSC127-2012-01 Start Date*: 2015-07-29
    Sponsor Name:Derma Sciencs Inc
    Full Title: A Randomized, Double-Blind, Parallel-group, Vehicle-controlled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Aclerastide (DSC127) in Treating Non-healing Foot Ulcers in Subjects wit...
    Medical condition: Diabetic Foot Ulcers
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Prematurely Ended) LT (Prematurely Ended) EE (Prematurely Ended) HU (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2018-001653-27 Sponsor Protocol Number: MarsyasII Start Date*: 2019-12-20
    Sponsor Name:Aposcience AG
    Full Title: A randomized, placebo-controlled, double-blind study to evaluate safety and dose dependent clinical efficacy of APO-2 at three different doses in patients with diabetic foot ulcer (MARSYAS II)
    Medical condition: Diabetic Foot Ulcer
    Disease: Version SOC Term Classification Code Term Level
    24.0 100000004858 10012664 Diabetic foot ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed) CZ (Completed) DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-000510-22 Sponsor Protocol Number: 1-2014.4 Start Date*: 2015-07-28
    Sponsor Name:Banc de Sang i Teixits
    Full Title: CLINICAL EFFICACY OF PLATELET GEL FROM CORD BLOOD FOR THE TREATMENT OF DIABETIC FOOT ULCERS
    Medical condition: Diabetic foot ulcers
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004858 10012664 Diabetic foot ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-010062-33 Sponsor Protocol Number: ABH-DERMAGRAFT-001-08 Start Date*: 2009-09-24
    Sponsor Name:Advanced BioHealing Inc
    Full Title: A Prospective, Multi-center, Randomized, Controlled Clinical Investigation of Dermagraft® in Subjects with Venous Leg Ulcers
    Medical condition: Venous leg ulcers
    Disease: Version SOC Term Classification Code Term Level
    9.1 10024134 Leg ulcer (exc varicose) LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) SE (Completed) GB (Completed) EE (Completed) AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-001566-90 Sponsor Protocol Number: A6301086 Start Date*: 2008-06-19
    Sponsor Name:Pfizer Limited, Ramsgate Road, Sandwich, Kent
    Full Title: A 6 MONTH, PROSPECTIVE, OPEN-LABEL MULTIPLE CENTER EXTENSION TRIAL TO EVALUATE THE LONG TERM SAFETY AND SUSTAINED EFFICACY OF FRAGMIN IN THE TREATMENT OF CHRONIC FOOT ULCERS IN DIABETIC PATIENTS WI...
    Medical condition: Diabetic Foot Ulcer
    Disease: Version SOC Term Classification Code Term Level
    9.1 10012664 Diabetic foot ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) SE (Completed) ES (Completed) NL (Prematurely Ended) CZ (Completed) FR (Completed) AT (Completed) DK (Prematurely Ended) FI (Prematurely Ended) BE (Completed) LT (Prematurely Ended) DE (Prematurely Ended) IT (Prematurely Ended) GR (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-000091-40 Sponsor Protocol Number: RS03-2004 Start Date*: 2005-11-08
    Sponsor Name:ApoPharma Inc.
    Full Title: Pivotal Study to Evaluate the Efficacy and Safety of Dermal - Living Skin Replacement (Dermal – LSR) in the Treatment of Chronic Diabetic Foot Ulcers
    Medical condition: Chronic Diabetic Foot Ulcers
    Disease: Version SOC Term Classification Code Term Level
    9.0 10012664 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-003402-25 Sponsor Protocol Number: OCT-UKE-2011 Start Date*: 2011-12-13
    Sponsor Name:Schülke & Mayr GmbH
    Full Title: Randomized, Double-blind, Single-center, Placebo-controlled Study to evaluate the Efficacy of octenisept® in Patients with Chronic Wounds.
    Medical condition: Chronic leg ulcers
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004858 10068310 Leg ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2020-001392-32 Sponsor Protocol Number: SC-VLU-001 Start Date*: 2021-11-10
    Sponsor Name:SolasCure Ltd
    Full Title: An adaptive open label, multiple ascending dose study of the safety, tolerability and bio-effect of Aurase for wound debridement in patients with venous leg ulcers and diabetic foot ulcers (CLEANVL...
    Medical condition: Venous Leg Ulcer Diabetic Foot Ulcer
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004858 10066677 Chronic leg ulcer LLT
    24.0 100000004858 10012664 Diabetic foot ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2007-004831-47 Sponsor Protocol Number: TWO2-001 Start Date*: 2007-11-30
    Sponsor Name:Linde Gas Therapeutics
    Full Title: Topical Wound Oxygen vs. Compression Therapy in the Management of Refractory, Non-Healing Venous Leg Ulcers; A prospective Randomised Controlled Trial
    Medical condition: Chronic, refarctory, non-healing venous ulcers with a duration of more than two years.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047260 Venous ulceration LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-005784-10 Sponsor Protocol Number: A6301083 Start Date*: 2007-12-21
    Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, NY 10017
    Full Title: A 6 MONTH, PROSPECTIVE, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTIPLE CENTER TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF FRAGMIN IN THE TREATMENT OF CHRONIC NEUROISCHAEMIC...
    Medical condition: Diabetic Foot Ulcer
    Disease: Version SOC Term Classification Code Term Level
    9.1 10012664 Diabetic foot ulcer LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended) NL (Completed) GB (Prematurely Ended) DK (Prematurely Ended) LT (Prematurely Ended) FI (Prematurely Ended) FR (Completed) ES (Completed) GR (Completed) CZ (Completed) AT (Completed) BE (Completed) IT (Prematurely Ended) DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2015-002196-15 Sponsor Protocol Number: DSC127-2012-02 Start Date*: 2015-07-29
    Sponsor Name:Derma Sciencs Inc
    Full Title: A Randomized, Double-Blind, Parallel-group, Vehicle and Standard of Care-controlled Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Aclerastide (DSC127) in Treating Non-healing Foot U...
    Medical condition: Diabetic Foot Ulcers
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Prematurely Ended) EE (Prematurely Ended) HU (Prematurely Ended)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 19 19:28:43 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA